|Articles|February 1, 2009
What are your trilostane dosing and monitoring recommendations in dogs with hyperadrenocorticism? Should I switch treatment from mitotane to trilostane in dogs being treated for hyperadrenocorticism? (4:47)
Author(s)David S. Bruyette, DVM, DACVIM
Dr. David Bruyette discusses how to administer and monitor trilostane in dogs with hyperadrenocorticism, including whether to switch affected patients from mitotane to trilostane.
Advertisement
video
Newsletter
From exam room tips to practice management insights, get trusted veterinary news delivered straight to your inbox—subscribe to dvm360.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on dvm360
1
AI system achieves perfect score on veterinary licensing exam
2
Canine oncology drug featured in Emmy-nominated documentary
3
Sneak peek: CDC cautions public about rabies exposure risk from feral cat colonies, and other news
4
Early Detection: Advancing Canine Cancer Care
5
